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We thank Black (2008) for his thoughtful
assembly of diverse perspectives including
ours on why another disastrous Mississippi
River flood occurred so soon after 1993. We
have an update that elucidates and quantifies
several key points of his article, particularly
that a) flood frequency and heights are
increasing, b) water levels for regulatory
“100-year” floods are profoundly under-
estimated, and c) misconceptions about risk
confound appropriate responses to flooding. 
At many sites in Iowa and Missouri the
Flood of 2008 neared or exceeded the record
“200-year” or “500-year” levels attained in
1993 [National Weather Service (NWS)
2008; U.S. Army Corps of Engineers
(USACE) 2008b], prompting many to won-
der how two such events could occur in only
15 years. Defenders of flow-frequency pre-
dictions cite their rigorous methods and
assure us that improbable outcomes are pos-
sible, even two “100-year” floods in consecu-
tive years (U.S. Geological Survey 2005).
Such arguments miss the key issue: Are the
flood probabilities calculated by USACE
(2004, 2008a) credible?
Problems with the USACE (2004,
2008a) probabilities are exemplified by
recent flooding at Hannibal, Missouri
(Figure 1). The record stage set in 1993
exceeded the calculated 500-year level,
whereas 2008 was a 200-year event. In
addition, 2001 suffered a 50- to 100-year
flood, 1986 and 1996 experienced 25- to
50-year floods, and five more years had 10-
to 25-year floods. Are these calculated
recurrence intervals reasonable, or is it more
likely that the dice, in effect, are loaded? 
Statistically, two 200-year floods would
likely not occur in an interval < 330 years,
but Hannibal has recently had far worse
(Figure 1). Two 500-year floods would prob-
ably not occur in < 840 years, yet two such
floods recently occurred at Canton, Missouri,
and Burlington, Iowa. A chi-square statistical
test rejects the assumed correctness of the
USACE frequencies with 99.9% confidence.
The 100-year flood stage at Hannibal should
be realistically redefined as a 10-year flood, as
reported by Black (2008). 
Because floods are becoming more fre-
quent and more severe over much of the
Mississippi River basin (Black 2008; Criss
and Shock 2001; Remo and Pinter 2007),
statistical calculations based on the histori-
cal record are not appropriate predictors of
future flooding, particularly for extreme
events (Klemes 2000). The likelihood of
attaining a given flood stage today is not
the same as it was a century ago, and
besides, the record is far too short to calcu-
late what a 200-year or a 500-year flood
might be. 
As Black (2008) discussed, calculated
flood probabilities are not merely academic.
The Federal Emergency Management
Agency (FEMA) and the National Flood
Insurance Program use these calculations to
delimit 100-year flood zones and to
set insurance requirements and rates.
Understated risk burdens everyone with
debt (Crichton 2002; Davidson 2005) and
places humans and property at risk from
water that is not only too high but also
laden with contaminants and sediment.
Unfortunately, erroneous calculations
(USACE 2004, 2008a) are being used in
the very latest proposals (USACE 2008c)
for flood protection and ecosystem restora-
tion. We need to use realistic concepts
about flooding in our management plans. 
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Longer Rodent Bioassay Fails to
Address 2-Year Bioassay’s Flaws
doi:10.1289/ehp.11964
In their commentary, Huff et al. (2008) pro-
posed that exposing experimental animals to
test substances in utero and for 30 months or
until their natural deaths increases the sensi-
tivity of bioassays, avoids false negative
results, and strengthens the value and validity
of results. Instead, longer exposure results in
increased numbers of spontaneously arising
tumors, as well as increased cost and animal
suffering, while failing to address the bio-
assay’s fundamental flaws.
Although it is troubling when the bio-
assay produces false negative results, a far
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Figure 1. Mississippi River flood levels recorded at
Hannibal over the last 25 years [right (NWS 2008;
USACE 2008b)] compared with the theoretical
stages for 2-year to 500-year floods [left (USACE
2004, 2008a)].more pervasive problem is that of false posi-
tives. In our analysis of > 500 National
Toxicology Program (NTP) bioassays
[People for the Ethical Treatment of
Animals (PETA) 2006], we found that more
than half of the substances evaluated (259)
produced evidence of carcinogenicity in at
least one group of animals, but only about
one-third of these (89) were subsequently
classified as known or probable human car-
cinogens by the NTP itself. Even fewer of
the substances, 40 and 16, respectively, were
classified as carcinogens by the U.S.
Environmental Protection Agency (EPA)
and the International Agency for Research
on Cancer (PETA 2006). This high false-
positive rate is thought to be largely an indi-
rect effect of increased cell proliferation in
response to cell injury and death caused by
the near toxic doses of test substances used
in the bioassay (Gaylor 2005). Species-
specific modes of action operating in rats or
mice but not in humans, such as those
mediated by 2µ-globulin, peroxisomes, and
thyroid-stimulating hormone, also con-
tribute to the high rate of false positives
(Cohen 2004).
Huff et al. (2008) asserted that one of
the “well-accepted observations” upon
which the “relevance of experimental bio-
assays to humans” rests is that “findings
from independently conducted bioassays on
the same chemicals are consistent.” In fact,
in a comparison of 121 bioassays from the
NTP database with those in the published
scientific literature, Gottmann et al. (2001)
found that the studies produced consistent
results only 57% of the time.
Huff et al. (2008) cited questions about
the safety of aspartame raised by 3-year
bioassays conducted by the Ramazzini
Foundation to support their conclusions.
Although they noted that the European
Food Safety Authority (FSA) and the U.S.
Food and Drug Administration (FDA) dis-
pute these studies’ conclusions, the FSA’s
Committee on Carcinogenicity (COC
2006) observed that 
In view of the inadequacies in design of the
[Ramazzini Foundation] study and the use of rats
with a high concurrent infection rate, the COC
considered that no valid conclusions could be
derived from it.
Further, the COC noted that groups of ani-
mals fed aspartame had lower body weights
and thus lived longer, which may have com-
promised the results by leading to an appar-
ent increase in spontaneously arising tumors.
Considering that lower body weights are
typically observed among animals in the bio-
assay’s experimental groups, this is likely to
generally confound the interpretation of
longer bioassays.
We must stress that animals suffer during
the bioassay: They live in the barren, stressful
conditions of the laboratory—often includ-
ing daily forced feeding or inhalation—and
many also suffer from exposure to near toxic
doses of test substances. These exposures
often produce lethargy, anemia, diarrhea,
weight loss, and other symptoms of sickness
and distress. The proposal of Huff et al.
(2008) to extend the length of the bioassay
would obviously result in a proportional
increase in this suffering.
Further, extending the bioassay runs
counter to current trends in regulatory test-
ing. Concern for the suffering of animals
has caused regulatory agencies to review the
usefulness of long-term studies, resulting in
elimination of the 1-year dog toxicity test
(U.S. EPA 2007) and an international
effort to replace the two-generation repro-
ductive toxicity test (Cooper et al. 2006).
Huff et al.’s proposal thus clearly represents
a step backward for toxicological science.
According to the NTP’s own estimates,
each bioassay requires 5 years to plan, con-
duct, and evaluate; 860 animals to be killed;
and $2–$4 million. As a result, the NTP
has conducted an average of only 12 bio-
assays/year over the past several decades.
Considering that humans are thought to be
exposed to approximately 80,000 environ-
mental toxicants (Ward et al. 2003), it
would take more than 32 millenia, 68 mil-
lion animals, and $160 billion to test them
all at this rate. Once again, extending the
length of the bioassay would only increase
these already ridiculous numbers.
The time has clearly come for antiquated
animal tests such as the bioassay to be aban-
doned in favor of modern, human-relevant
methods such as epidemiologic studies, high-
throughput in vitro methods, and computa-
tional toxicology.
The authors are employed by People for the
Ethical Treatment of Animals, an animal advo-
cacy organization.
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Longer Rodent Bioassay:
Huff et al. Respond
doi:10.1289/ehp.11964R
We appreciate and sympathize with
Manuppello and Willett’s concerns about the
inappropriate use of animals in research.
Significant advances in animal protection have
been secured in the United States through
standards that have been promulgated, and we
hope that further progress will be made.
Drugs are developed today often using
methods that evaluate impacts in vitro and
take advantage of innovations in three-
dimensional structure-activity modeling.
Still, because in vitro and theoretical meth-
ods are imperfect and because relying on
them alone could result in considerable harm
to humans, drugs and other chemicals are
studied—and are required to be studied—in
animals before being tested on humans or
introduced into the human environment.
Epidemiologic studies, high-throughput
in vitro methods, and computational toxi-
cology would be preferable to animal
research if they provided sensitive, accurate
measures of human risk. Unfortunately,
epidemiology studies are insufficiently
sensitive, in vitro methods are insufficiently
predictive, and computational toxicology is
insufficiently developed. Ideally, govern-
ment would provide much greater funding
to further develop those and other tech-
nologies to expedite less expensive and more
accurate means of risk assessments and
reduce the need for animal bioassays. 
The fact that positive animal bioassays
have not always been mirrored in positive
human findings provides an ethical public
policy challenge. If we must wait for
human evidence of cancer before acting to
prevent future cases, then we are conducting
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controls—especially if animal evidence
already indicated a risk.
Current standards for concluding that
an agent is a human carcinogen require sta-
tistically significant proof of sufficient num-
bers of cases of cancer in humans with
measured or estimated exposures. Human
cancers can take up to several decades to
become evident in populations. Surveillance
of the workplace and general environmental
monitoring are not being widely conducted
at this time. The last national survey of
workplace carcinogens was conducted in
the last century, and no new survey is
planned at this time. Furthermore, except
in cases where the cancer risks are enor-
mous, such as tobacco smoking and work-
place exposure to asbestos, linking a
chemical outside the workplace, for exam-
ple, in the diet, air, or water, to human can-
cers is virtually impossible.
In fact, the 2.5- to 3-year bioassays of
the European Ramazzini Foundation of
Oncology and Environmental Sciences on
toluene, benzene, radiation, and aspartame
(Soffritti et al. 2004, 2007) consistently
indicate that the results of 2-year studies—
the normal length of rat studies—under-
predict potency/carcinogenicity and that
true lifetime studies more accurately reflect
cumulative impacts.
In addition, the paradigm-busting
work of researchers on transgenerational
effects, male-mediated teratogenesis, and
the general critical impact of early develop-
mental windows all strengthen the case for
regarding 2-year postnatal bioassays as
incomplete indications of toxicity/carcino-
genicity (e.g., Dolinoy et al. 2007; Newbold
and McLachlan 1982; Sonne et al. 2008;
Swan et al. 2006).
In our commentary (Huff et al. 2008)
we indicated that 2-year results tend to be
biased toward the null hypothesis. In no
way do we state or imply that a positive
finding in a 2-year assay would be negated
by a longer test, nor do we indicate the con-
trary, that the absence of a positive finding
in a 2-year assay should be construed as
proof that there is no impact.
The current typical bioassay has served
society well, but it does have several flaws: It
cannot provide adequate prediction for the
growing proportion of the population that is
now living well into their eighties and
nineties; it is not designed to evaluate the
impact of prenatal exposures on later life;
rodents are not a perfect model for humans;
and countless animals must be sacrificed to
obtain admittedly imperfect results.
By focusing improved bioassays on high-
volume chemicals for which there are a priori
grounds for concern, current approaches
promise to yield the greatest good with the
least harm. Simultaneously, more research
must be done to identify fast, sensitive, accu-
rate, and economical means of identifying
chemicals that might be harmful to humans.
M.F.J. is employed by an advocacy organiza-
tion that supports stronger testing requirements
for chemicals in food. The other authors declare
they have no competing financial interests.
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ERRATA
A typographical error on page A480 of the November Focus article [“Linking TB and the Environment: An Overlooked Mitigation Strategy,”
Environ Health Perspect 116:A478–A485 (2008)] misidentified DOTS as a 66-month treatment regimen. DOTS is actually a 6-month 
regimen. EHP regrets the error.
Brauer et al. [Environ Health Perspect 116:680–686 (2008)] identified several minor errors in their recent publication. First, in the “Results” section
of the abstract, the values given for low full-term birth weight (LBW) were incorrect; “Residence within 50 m of highways was associated with … a
22% (95% CI, 0.81–1.87) increase in LBW.” There were also inconsistencies in the description and application of missing data rules across all pol-
lutants (Tables 3–7); the description of these rules in the text (bottom of p. 681) should read “For both approaches, a subject was considered miss-
ing if there was a gap of > 5 consecutive days in air monitoring data or if there were > 10 missing days within the term of the pregnancy.” 
In Tables 2, 3, and 5, results for the small-for-gestational-age (SGA) outcome were presented for births restricted to gestational periods of
≥ 37 weeks, and not for the full cohort; in Tables 2, 3, 5, and 7, coding errors in the application of birth weight and gestational period cutoffs
resulted in slight differences in the number of cases of SGA and preterm births; and in Tables 5 and 6, one road proximity measure was not
labeled correctly: < 150 m from a major road/highway was actually 50–150 m from a major road/highway. 
Correcting these errors results in small changes in the numbers of subjects included in specific analyses and slight differences in odds
ratios (ORs) but does not alter our overall findings. The corrected tables are presented below.
The authors apologize for the errors.
Table 2. Prevalence of SGA, LBW and pre-term birth in the cohort (n = 70,249).
Outcome No. (%)
SGA (< 10th percentile) 7,217 (10.3)
LBW (< 2,500 g at ≥ 37 weeksa) 897 (1.3)
Gestation < 37 weeks 3,748 (5.3)
Gestation < 35 weeks 1,247 (1.8)
Gestation < 30 weeks 241 (0.3)
an = 66,501 births at full (≥ 37 weeks) term.
Table 3. Crude and adjusted ORsa for SGA.
Exposure  SGA cases Crude OR Adjustedb OR 
(entire pregnancy) (n) (95% CI) (95% CI)
NO–IDW (10 μg/m3) 7,215 1.02 (1.00–1.05) 1.05 (1.02–1.08)
NO–LUR (10 μg/m3) 7,023 1.03 (1.01–1.05) 1.03 (1.00–1.05)
NO2–IDW (10 μg/m3) 7,215 1.12 (1.08–1.16) 1.14 (1.09–1.18)
NO2–LUR (10 μg/m3) 7,023 1.04 (0.99–1.10) 0.98 (0.93- 1.04)
CO–IDW (100 μg/m3) 5,779 1.04 (1.01–1.06) 1.06 (1.03–1.08)
PM2.5–IDW (1 μg/m3) 5,818 1.01 (0.97–1.05) 1.06 (1.00–1.12)
PM2.5–LUR (1 μg/m3) 7,023 1.03 (1.02–1.05) 1.01 (1.00–1.03)
BC–LUR (10–5/m) 7,023 1.03 (1.01–1.05) 1.01 (0.99–1.03)
PM10–IDW (1 μg/m3) 7,217 1.02 (1.00–1.04) 1.03 (1.00–1.07)
SO2–IDW (1 μg/m3) 7,138 1.00 (0.99–1.02) 1.01 (1.00–1.02)
BC, black carbon. 
aORs per standardized increases (indicated in parentheses), roughly corresponding to
interquartile range. bAdjusted for infant sex, First Nations status, parity, maternal age,
maternal smoking during pregnancy, month–year of birth, income (quintile-census),
maternal education (quartile-census).
Table 4. Crude and adjusted ORsa for LBW at full (≥ 37 weeks) term.
Exposure LBW cases Crude OR Adjustedb OR
(entire pregnancy) (n) (95% CI) (95% CI)
NO–IDW (10 μg/m3) 897 1.02 (0.96–1.09) 1.03 (0.96–1.11)
NO–LUR (10 μg/m3) 877 1.03 (0.97–1.09) 1.02 (0.95–1.08)
NO2–IDW (10 μg/m3) 897 1.11 (1.02–1.22) 1.10 (1.00–1.22)
NO2–LUR (10 μg/m3) 877 1.02 (0.89–1.18) 0.93 (0.80–1.08)
CO–IDW (100 μg/m3) 730 1.03 (0.97–1.09) 1.03 (0.96–1.11)
PM2.5–IDW (1 μg/m3) 724 0.96 (0.87–1.07) 1.00 (0.85–1.17)
PM2.5–LUR (1μg/m3) 877 1.05 (1.02–1.09) 1.03 (0.99–1.07)
BC–LUR (10–5/m) 877 1.03 (0.97–1.09) 1.01 (0.95–1.07)
PM10–IDW (1 μg/m3) 897 1.01 (0.95–1.08) 1.04 (0.95–1.13)
SO2–IDW (1 μg/m3) 891 0.99 (0.96–1.02) 0.98 (0.96–1.01)
BC, black carbon. 
aORs per standardized increases (indicated in parentheses), roughly corresponding to
interquartile range. bAdjusted for infant sex, First Nations status, parity, maternal age,
maternal smoking during pregnancy, month–year of birth, income (quintile-census),
maternal education (quartile-census).
Table 5. Crude and adjusted ORs for SGA and road proximity.
No. of SGA cases Crude OR Adjusteda OR 
Measure (% of total subjects) (95% CI) (95% CI)
< 150 m highwayb or 1,374 (1.96) 1.04 (0.98–1.11) 1.02 (0.96–1.08)
< 50 major roadc
< 50 m highway 176 (0.25) 1.25 (1.07–1.47) 1.21 (1.03–1.42) 
50–150 m highway 404 (0.57) 0.95 (0.86–1.06) 0.92 (0.83–1.03) 
< 50 m major road 841 (1.20) 1.06 (0.98–1.14) 1.04 (0.97–1.13) 
50–150 m major road 1,592 (2.27) 1.05 (0.99–1.11) 1.04 (0.98–1.10) 
aAdjusted for infant sex, First Nations status, parity, maternal age, maternal smoking during
pregnancy, month–year of birth, income (quintile-census), maternal education (quartile-
census). bDMTI type 1 and 2 road (expressway: 114,000 vehicles/day; principal highway:
21,000 vehicles/day). cDMTI type 3 and 4 road (secondary highway: 18,000 vehicles/day;
major road: 15,000 vehicles/day).
Table 6. Crude and adjusted odds ratios for LBW at full term and road proximity.
No. of LBW cases Crude OR Adjusteda OR  
Measure (% of total subjects) (95% CI) (95% CI)
< 150 m highwayb or 169 (0.25) 1.03 (0.87–1.22) 0.99 (0.84–1.18)
< 50 major roadc
< 50 m highway 24 (0.04) 1.37 (0.91–2.07) 1.28 (0.85–1.93)
50–150 m highway 55 (0.08) 1.05 (0.80–1.39) 1.01 (0.77–1.33)
< 50 m major road 100 (0.15) 1.00 (0.81–1.24) 0.99 (0.80–1.22)
50–150 m major road 184 (0.28) 0.95 (0.81–1.12) 0.94 (0.80–1.10)
aAdjusted for infant sex, First Nations status, parity, maternal age, maternal smoking during
pregnancy, month–year of birth, income (quintile-census), maternal education (quartile-
census). bDMTI type 1 and 2 road (expressway: 114,000 vehicles/day; principal highway:
21,000 vehicles/day). cDMTI type 3 and 4 road (secondary highway: 18,000 vehicles/day;
major road: 15,000 vehicles/day).
Table 7. Crude and adjusted ORsa for preterm births < 30 weeks.
Exposure Cases Crude OR Adjustedb OR 
(entire pregnancy) (n) (95% CI) (95% CI)
NO–IDW (10 μg/m3) 241 1.15 (1.03–1.28) 1.18 (1.03–1.35)
NO–LUR (10 μg/m3) 235 1.09 (0.98–1.21) 1.06 (0.94–1.19)
NO2–IDW (10 μg/m3) 241 1.12 (0.94–1.33) 1.10 (0.91–1.34)
NO2–LUR (10 μg/m3) 235 1.15 (0.88–1.50) 1.09 (0.82–1.45)
CO–IDW (100 μg/m3) 192 1.06 (0.94–1.19) 1.04 (0.91–1.20)
PM2.5–IDW (1 μg/m3) 200 1.22 (1.01–1.48) 2.01 (1.38–2.92)
PM2.5–LUR (1μg/m3) 235 1.07 (0.99–1.14) 1.05 (0.97–1.13)
BC–LUR (10–5/m) 235 1.02 (0.92–1.14) 1.00 (0.90–1.11)
PM10–IDW (1 μg/m3) 241 1.17 (1.04–1.32) 1.18 (1.01–1.38)
SO2–IDW (1 μg/m3) 238 1.02 (0.97–1.07) 1.01 (0.95–1.06)
BC, black carbon. 
aORs per standardized increases (in parentheses), roughly corresponding to interquartile
range. bAdjusted for infant sex, First Nations status, parity, maternal age, maternal smok-
ing during pregnancy, month–year of birth, income (quintile-census), maternal education
(quartile-census).